This just came into my email inbox:
“Dong-A PharmTech Co., Ltd. [a Korean drug company] announced today that it has completed a 340 patient phase 2b ‘at-home’ clinical study for udenafil, its new long acting (12 hour half-life) oral phosphodiesterase type 5 (PDE5) inhibitor for erectile dysfunction (ED).”
Does anyone else find this amusing?
Good grief Mr Mack!
How puerile can your humor get?
Please cease and desist!!
Kind regards
http://www.yesicanusechopsticks.com/thesequel/photos/DongMen.jpg
I think you have been reading PharmaGiles again…